AI Portfolio Summary
In 2026 Q1, Jones Hill Capital LP maintained a portfolio of 26 distinct positions. The most significant new addition to the portfolio was BIOMARIN PHARMACEUTI, which now represents 15.36% of the total fund value.
Total Positions
26
Quarter
2026 Q1
Top Holding
BMRN (15.4%)
Top 10 Concentration
73.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-26 of 26
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 15.36% | — |
#1
Prev: #—
|
9.5 | 1,268,390 | no change |
NEW
|
1,268,390 | $71,651,351 |
$56.49
-1.8%
|
2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 10.40% | — |
#2
Prev: #—
|
9.0 | 108,603 | no change |
NEW
|
108,603 | $48,495,584 |
$446.54
-1.8%
|
2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
PCVX
VAXCYTE INC
|
Healthcare | 8.03% | — |
#3
Prev: #—
|
7.7 | 644,831 | no change |
NEW
|
644,831 | $37,471,129 |
$58.11
+0.5%
|
2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
NUVL
NUVALENT INC
|
Healthcare | 6.61% | — |
#4
Prev: #—
|
6.6 | 300,830 | no change |
NEW
|
300,830 | $30,820,034 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 5.93% | — |
#5
Prev: #—
|
6.4 | 909,207 | no change |
NEW
|
909,207 | $27,639,893 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 5.89% | — |
#6
Prev: #—
|
5.9 | 521,237 | no change |
NEW
|
521,237 | $27,479,615 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 5.37% | — |
#7
Prev: #—
|
5.6 | 1,260,136 | no change |
NEW
|
1,260,136 | $25,064,105 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 5.25% | — |
#8
Prev: #—
|
5.6 | 318,591 | no change |
NEW
|
318,591 | $24,499,648 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 5.23% | — |
#9
Prev: #—
|
5.6 | 1,165,557 | no change |
NEW
|
1,165,557 | $24,418,419 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 4.98% | — |
#10
Prev: #—
|
5.5 | 593,040 | no change |
NEW
|
593,040 | $23,247,168 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 4.76% | — |
#11
Prev: #—
|
5.4 | 1,598,794 | no change |
NEW
|
1,598,794 | $22,223,237 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ARGX
ARGENX SE
|
Healthcare | 4.07% | — |
#12
Prev: #—
|
5.1 | 25,995 | no change |
NEW
|
25,995 | $18,982,849 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 2.91% | — |
#13
Prev: #—
|
4.7 | 1,771,926 | no change |
NEW
|
1,771,926 | $13,590,672 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 2.30% | — |
#14
Prev: #—
|
4.4 | 1,198,213 | no change |
NEW
|
1,198,213 | $10,735,988 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 2.19% | — |
#15
Prev: #—
|
4.4 | 2,383,031 | no change |
NEW
|
2,383,031 | $10,223,203 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.48% | — |
#16
Prev: #—
|
4.1 | 140,843 | no change |
NEW
|
140,843 | $6,908,349 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 1.44% | — |
#17
Prev: #—
|
4.1 | 513,053 | no change |
NEW
|
513,053 | $6,700,472 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
VERADERMICS INC
|
—
|
Unknown | 1.37% | — |
#18
Prev: #—
|
4.0 | 100,843 | no change |
NEW
|
100,843 | $6,368,235 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
TNXP
TONIX PHARMACEU...
|
Healthcare | 1.33% | — |
#19
Prev: #—
|
4.0 | 452,116 | no change |
NEW
|
452,116 | $6,216,595 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 1.04% | — |
#20
Prev: #—
|
3.9 | 100,593 | no change |
NEW
|
100,593 | $4,848,583 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 1.01% | — |
#21
Prev: #—
|
3.9 | 374,010 | no change |
NEW
|
374,010 | $4,720,006 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.01% | — |
#22
Prev: #—
|
3.9 | 167,014 | no change |
NEW
|
167,014 | $4,718,146 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.95% | — |
#23
Prev: #—
|
3.9 | 370,175 | no change |
NEW
|
370,175 | $4,416,188 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 0.51% | — |
#24
Prev: #—
|
3.7 | 342,752 | no change |
NEW
|
342,752 | $2,385,554 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.34% | — |
#25
Prev: #—
|
3.6 | 301,604 | no change |
NEW
|
301,604 | $1,589,453 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 0.23% | — |
#26
Prev: #—
|
3.6 | 45,809 | no change |
NEW
|
45,809 | $1,056,814 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-26 of 26 holdings